Blue Jet Healthcare Limited (NSE:BLUEJET)
India · Delayed Price · Currency is INR 376.10
+0.50 (0.13%)
At close: Mar 10, 2026
Blue Jet Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 10,531 | 10,300 | 7,116 | 7,210 | 6,835 | 4,989 | |
Revenue Growth (YoY) | 20.56% | 44.74% | -1.30% | 5.49% | 36.99% | -7.29% |
Cost of Revenue | 4,953 | 4,695 | 3,212 | 3,427 | 2,946 | 1,695 |
Gross Profit | 5,578 | 5,605 | 3,904 | 3,783 | 3,889 | 3,295 |
Selling, General & Admin | 710.44 | 609.97 | 531.85 | 418.97 | 330.3 | 289.55 |
Other Operating Expenses | 1,239 | 1,218 | 1,080 | 1,173 | 1,066 | 944.67 |
Operating Expenses | 2,175 | 2,006 | 1,893 | 1,843 | 1,614 | 1,431 |
Operating Income | 3,403 | 3,599 | 2,011 | 1,940 | 2,275 | 1,864 |
Interest Expense | -56.9 | -0.98 | -1.61 | -13.59 | -32.82 | -46.91 |
Interest & Investment Income | 53.99 | 53.99 | 28.18 | 5.87 | 4.38 | 6.16 |
Currency Exchange Gain (Loss) | 183.03 | 183.03 | 99.27 | 147.66 | 167.53 | 46.22 |
Other Non Operating Income (Expenses) | 156.41 | 39.38 | 14.34 | 13.89 | 2.38 | -5.06 |
EBT Excluding Unusual Items | 3,740 | 3,875 | 2,152 | 2,094 | 2,417 | 1,864 |
Gain (Loss) on Sale of Investments | 183.65 | 183.65 | 142.09 | 71.11 | 19.36 | 34.28 |
Gain (Loss) on Sale of Assets | 2.51 | 2.51 | 4.72 | 1.03 | 0.29 | 1.04 |
Asset Writedown | - | - | - | - | -3.85 | - |
Other Unusual Items | - | - | -97.43 | - | - | -53.07 |
Pretax Income | 3,926 | 4,061 | 2,201 | 2,166 | 2,432 | 1,847 |
Income Tax Expense | 990.09 | 1,009 | 563.44 | 565.84 | 616.39 | 488.7 |
Earnings From Continuing Operations | 2,936 | 3,052 | 1,638 | 1,600 | 1,816 | 1,358 |
Minority Interest in Earnings | - | - | - | - | - | 26.28 |
Net Income | 2,936 | 3,052 | 1,638 | 1,600 | 1,816 | 1,384 |
Net Income to Common | 2,936 | 3,052 | 1,638 | 1,600 | 1,816 | 1,384 |
Net Income Growth | 25.05% | 86.38% | 2.33% | -11.88% | 31.19% | -4.44% |
Shares Outstanding (Basic) | 173 | 173 | 173 | 173 | 173 | 173 |
Shares Outstanding (Diluted) | 173 | 173 | 173 | 173 | 173 | 173 |
EPS (Basic) | 16.92 | 17.59 | 9.44 | 9.23 | 10.47 | 7.98 |
EPS (Diluted) | 16.92 | 17.59 | 9.44 | 9.23 | 10.47 | 7.98 |
EPS Growth | 24.95% | 86.33% | 2.33% | -11.88% | 31.19% | -4.44% |
Free Cash Flow | - | -341.16 | 683.96 | 822.85 | 1,246 | 971.62 |
Free Cash Flow Per Share | - | -1.97 | 3.94 | 4.74 | 7.18 | 5.60 |
Dividend Per Share | - | 1.200 | 1.000 | - | - | - |
Dividend Growth | - | 20.00% | - | - | - | - |
Gross Margin | 52.96% | 54.42% | 54.86% | 52.47% | 56.89% | 66.04% |
Operating Margin | 32.31% | 34.95% | 28.27% | 26.91% | 33.29% | 37.36% |
Profit Margin | 27.88% | 29.63% | 23.01% | 22.20% | 26.57% | 27.74% |
Free Cash Flow Margin | - | -3.31% | 9.61% | 11.41% | 18.23% | 19.47% |
EBITDA | 3,486 | 3,760 | 2,275 | 2,148 | 2,484 | 2,059 |
EBITDA Margin | 33.10% | 36.50% | 31.98% | 29.80% | 36.35% | 41.28% |
D&A For EBITDA | 82.72 | 160.41 | 264 | 208.11 | 209.35 | 195.52 |
EBIT | 3,403 | 3,599 | 2,011 | 1,940 | 2,275 | 1,864 |
EBIT Margin | 32.31% | 34.95% | 28.27% | 26.91% | 33.29% | 37.36% |
Effective Tax Rate | 25.22% | 24.84% | 25.60% | 26.12% | 25.34% | 26.46% |
Revenue as Reported | 11,111 | 10,762 | 7,405 | 7,449 | 7,029 | 5,078 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.